| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-108 |
Sentence |
denotes |
Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer. |
| T2 |
109-172 |
Sentence |
denotes |
Aberrant glycosylation is a common feature of malignant change. |
| T3 |
173-390 |
Sentence |
denotes |
Changes in mucin-type O-linked glycosylation in breast cancer can result in the expression of truncated core 1-based sialylated glycans rather than the core 2-based glycans observed in normal mammary epithelium cells. |
| T4 |
391-540 |
Sentence |
denotes |
This has been shown, in part, to be due to changes in the expression of glycosyltransferases, including the up-regulation of some sialyltransferases. |
| T5 |
541-869 |
Sentence |
denotes |
Using the breast cancer cell line T47D, we have shown that PGE2, one of the final products of the cyclooxygenase-2 (COX-2) pathway, can induce the mRNA expression of the sialyltransferase α-2,3-sialyltransferase-3 (ST3Gal-I), resulting in increased sialyltransferase activity, demonstrated by a reduction in PNA lectin staining. |
| T6 |
870-1069 |
Sentence |
denotes |
Induction of COX-2 in the MDA-MB-231 breast cancer cell line also results in the increased expression of ST3Gal-I, leading to increased sialylation of the substrate of ST3Gal-I, core 1 Galβ1,3GalNAc. |
| T7 |
1070-1158 |
Sentence |
denotes |
This effect on sialylation could be reversed by the selective COX-2 inhibitor celecoxib. |
| T8 |
1159-1312 |
Sentence |
denotes |
The use of siRNA to knock down COX-2 and overexpression of COX-2 in MDA-MD-231 cells confirmed the involvement of COX-2 in the up-regulation of ST3Gal-I. |
| T9 |
1313-1458 |
Sentence |
denotes |
Moreover, analysis of the expression of ST3Gal-I and COX-2 by 74 primary breast cancers showed a significant correlation between the two enzymes. |
| T10 |
1459-1601 |
Sentence |
denotes |
COX-2 expression has been associated with a number of tumors, including breast cancer, where its expression is associated with poor prognoses. |
| T11 |
1602-1812 |
Sentence |
denotes |
Thus, these results suggest the intriguing possibility that some of the malignant characteristics associated with COX-2 expression may be via the influence that COX-2 exerts on the glycosylation of tumor cells. |